Business Description
Founded in Denmark in 1998, Genmab is a biotechnology company focused on creating antibody-based treatments for cancer and other serious diseases. Its commercial portfolio includes several approved therapies targeting blood cancers, cervical cancer, multiple myeloma, thyroid eye disease, and multiple sclerosis, among others. The company also has a broad pipeline of treatments in development spanning solid tumors, blood disorders, and neurological conditions, with research partnerships in place with major pharmaceutical companies including Johnson & Johnson, Pfizer, AbbVie, and Bristol Myers Squibb.
